Corindus Vascular Robotics raised $42 million last week by offering 11 million shares at $3.80 and going public on the NYSE MKT exchange, a special market for small-cap growth companies.
Corindus, which sells the CorPath robotic angioplasty system that aid stent placement during coronary angioplasties from the safety of a radiation-protected interventional work console, had previously been trading on the over-the-counter market.
Corindus joins other robotics-related publicly-traded healthcare companies such as Accuray, Cyberdyne, Mazor Robotics, Hansen Medical, Stereotaxis, Intuitive Surgical, Titan Medical, Stryker and Johnson & Johnson.
There has been much media attention recently to the stocks of robot manufacturers. Two items of particular interest are: